MyAverix Finance MyAverix Finance

KO

Korea Arlico Pharm Co. Ltd. (260660)

Korea Arlico Pharm Co. Ltd. (260660) is listed on KO. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 260660

P/E ratio
18.00

Korea Arlico Pharm Co. Ltd. (260660) — FAQ

What is 260660's P/E ratio?

The price-to-earnings (P/E) ratio for Korea Arlico Pharm Co. Ltd. (260660) is 18.00 (data as of 2026-03-23).

Does Korea Arlico Pharm Co. Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Korea Arlico Pharm Co. Ltd. (260660). Check the MyAverix Finance app for the latest dividend data.

What exchange is 260660 listed on?

260660 is listed on KO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play